Open AccessEight months of HeartMate II device support without drug therapy
Author(s) -
Kewal Krishan,
Sean Pinney,
Anelechi C. Anyanwu
Publication year - 2017
Publication title -
journal of the practice of cardiovascular sciences
Language(s) - English
Resource type - Journals
eISSN - 2454-2830
pISSN - 2395-5414
DOI - 10.4103/jpcs.jpcs_30_17
Subject(s) - medicine , ventricular assist device , anticoagulant therapy , incidence (geometry) , surgery , complication , medical therapy , cardiology , circulatory system , heart failure , intensive care medicine , physics , optics
Thromboembolic complication rates of 20%–30% were initially a major limitation to the widespread use of left ventricular assist devices. The success of the HeartMate (Thoratec, Corp., Pleasanton, CA, USA) device has been partly due to the reduced incidence of thromboembolic events, although anticoagulation regime has been recommended for this mechanical circulatory support. We here present a case with the placement of HeartMate II in a patient, noncompliant to medical therapy where device worked for 8 months without any anticoagulant or antiplatelet therapy